In The Loop Banner
Party In Your PPE. Health Care Logistics.

Implementing and Expanding Specialty Pharmacy Services
By Sangeeta Goel, PharmD, and Kaleigh Fisher, PharmD

As specialty pharmaceuticals continue to drive a substantial share of total drug spend, rigorous controls affect pharmacy's ability to access these products and maintain continuity of care for patients. To address this ongoing challenge, many organizations have established specialty pharmacies or are considering this option. To get started with an implementation or expansion, learn the essential program elements HERE.

Did You Know . . .
Despite a decrease in the number of new drug shortages in the United States, long-term active and ongoing shortages are not resolving. CLICK HERE to read about trends in existing shortages.

Editor's Pick

Ensuring Adherence to Oral Chemotherapy
By Megan May, PharmD, BCOP

Precluding the need for IV access and infusion center or hospital visits, oral chemotherapy treatment proves beneficial; patients often prefer oral chemotherapy over its IV counterpart due to its convenience. Oral chemotherapy use is accompanied by unique concerns, including ensuring patient adherence, managing side effects, educating patients on safe handling requirements, and avoiding food and drug interactions. To investigate establishing a system for monitoring and managing these drugs, CLICK HERE.

Your Subscription
You are receiving this message as a subscriber to Pharmacy Purchasing & Products. If you would like to unsubscribe from our newsletters, please visit

If you are not already a subscriber to Pharmacy Purchasing & Products and would like to subscribe please go to:

Please remember to add us to your address book to ensure that you continue to receive our emails in your inbox.

Sponsorship/Advertising Opportunities
Please contact your account manager at or call 201-670-0077, ext. 200.

In the Loop © 2018 Ridgewood Medical Media, LLC. You have permission to forward In the Loop, in its entirety only, provided this copyright notice remains part of your transmission. To subscribe to In the Loop, please send an email to: and type "Subscribe, (Your email address, and full name)" in the body.

All other rights reserved. None of this material may be reprinted without the express written permission of Ridgewood Medical Media, LLC.
340B Program. External Audits. Protect Your Program and Minimize Risk. Visante. A vision for moving healthcare forward.

FLUADĀ® influenza vaccine, adjuvanted. Health Care Professionals, Have you heard about FLUADĀ®? For adults 65+. Find out more >>;dc_trk_aid=412270718;dc_trk_cid=97068368;dc_lat=;dc_rdid=;tag_for_child_directed_treatment= FLUAD is a registered trademark of Seqirus UK Limited or its affiliates. Manufactured by: Seqirus Vaccines Limited Speke, Liverpool, L249GR, UL Distributed by: Seqirus USA Inc. 25 Deforest Avenue, Summit, NJ 07901, USA US/FLUD/1117/0070

NuAire Compounding Aseptic Containment Isolators are designed to help with your USP 800 compliance with features that assist with documentation and surveillance programs.

Baker. USP <800> Coming Dec 2019. New Legislation, Timing & Implications. 91 Weeks 04 Days. At Baker, we have the tools to help you get USP <800> compliant. Let Baker help.